Updates for Migraine Management in Primary Care
- CME / AMA PRA Category 1 Credit™
Based solely on clinical evaluation, the diagnosis of migraine can be challenging for clinicians. Its management typically requires lifestyle and trigger management, along with acute, preventive, or combination treatments. Recent migraine research has focused on the role of calcitonin gene-related peptide (CGRP), which is released in significant amounts during an acute attack and is chronically elevated in patients with chronic migraine.
The development of novel medications targeting the CGRP pathway could offer an effective option for patients with acute and chronic migraine. Primary care providers, including residents and fellows, will play an increasingly important role in identifying patients with migraine headache and ensuring they are properly diagnosed and appropriately treated. This CME activity will provide these clinicians with the latest evidence-based strategies and emerging therapies for migraine management.
Welcome and Introductions
Migraine: The Scope of the Problem
Pathophysiology of Migraine
Current and Emerging Agents
This activity is intended for residents and fellows, primary care providers, and allied healthcare providers who treat patients at risk for or who have migraine.
At the conclusion of this activity, participants should be able to demonstrate the ability to:
- Examine the epidemiology, differential diagnosis, and impact of migraine within the primary-care patient population
- Describe the pathophysiology of migraine, including the role of calcitonin gene-related peptide (CGRP)
- Delineate current standards of pharmacologic and nonpharmacologic management for the preventive and acute management of migraine
- Assess clinical safety and efficacy data for emerging therapeutic agents for the prevention and treatment of migraine
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
The Potomac Center for Medical Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit, the post-test, or evaluation, please email firstname.lastname@example.org.
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center Wynnewood, PA
A 2-time recipient of the Osler-Blockley Award for Excellence in Clinical Teaching from Thomas Jefferson University, Dr. Burke also has received the residents' award for best teacher from the Lankenau Internal Medicine house staff. She has been named Best Doctor for Women and, more recently, a Top Doctor by Main Line Today magazine. Dr. Burke lectures nationally and has published chapters and articles on numerous primary care and geriatric topics on CME websites and in publications such as the Journal of the American Osteopathic Association and Annals of Long-Term Care.
Co-Director, The Headache Center of Southern California
Dr. Schim is board-certified in neurology and has certification in headache medicine from the United Council of Neurologic Subspecialties. Dr. Schim also serves as Medical Director of the Stroke Program at Tri-City Medical Center, Immediate Past President of the Headache Cooperative of the Pacific, Chairperson and Director of the California Chapter of the Alliance for Patient Access (AfPA), and as a Board Member and Past President of the American Heart Association.
He has been involved in acute stroke care and prevention since 1990 and has been a leading headache clinician since 1992. He has helped build a very active, clinically based headache program with outpatient focus, which has helped set the standards of headache care. He has been involved on an ongoing basis with access-to-care issues as part of patient advocacy. He has been a clinical investigator in multiple clinical trials involving headache, pain, movement disorders, stroke and spasticity, among other topics. He has been an investigator and assisted in the development of novel migraine therapeutics, including multiple trials of CGRP blockade for migraine.
PGY-3 Internal Medicine
Lankenau Medical Center
Chief Resident, Internal Medicine Program
Lankenau Medical Center
DISCLOSURE/CONFLICT OF INTEREST STATEMENT
All persons in a position to control content of a continuing medical education program provided by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards of Commercial Support in advance of delivery of the activity to learners.
The content of this activity was vetted by an external reviewer to assure objectivity and that the activity is free of commercial bias.
Program Faculty Disclosures
The program faculty reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
M. Susan Burke, MD, FACP – Consultant/Independent Contractor: Merck; Speaker's Bureau: Merck; Speaker Training: Ferring Pharmaceuticals
Jack Schim, MD – Consultant/Honoraria/Speaker's Bureau: Acorda Therapeutics, Allergan, Amgen, Avanir, Depomed, ElectroCore, Lilly, Novartis, Pernix Therapeutics, Promius Pharma, Supernus, Teva, Upsher-Smith; Grant/Research Support: Alder, Allergan, Amgen, ElectroCore, Lilly, Teva; Stock/Shareholder: Alder
Christopher Damiano, DO, MPH – Nothing to disclose
Matthew Delmonico, DO – Nothing to disclose
Non-faculty Content Contributors Disclosures
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Kathy Merlo; Chad Williamson, MS, MBA, CMPP; Blair St. Amand; Lindsay Scott, PT, DPT, ATC: Nothing to disclose.
INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME CREDIT
Jointly provided by the Potomac Center for Medical Education and Rockpointe
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding, please visit www.lillygrantoffice.com.
Achieving New Treatment Goals in Multiple Sclerosis: Strategies for Initial Treatment Selection and Patient Engagement
Credits 1.00 (60 min)
FIGHTING THE UPHILL BATTLE: Current Evidence in Obesity Management
Credits 1.00 (60 min)
ON THE FRONT LINE OF A CRISIS: Improving the Care and Education of Patients with Opioid Use Disorder
Credits 1.00 (60 min)